Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Kashiwa
Clinical trial register · Japan

Clinical Trials in Kashiwa, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Japan and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2493 matching records held by the registry are in this view. Synced 22 Oct 2026, 03:19 UTC
2493
Studies in scope
all four open statuses
1263
Recruiting now
open to new participants
349
Lead sponsors
across recruiting studies
Top sites
Nagoya 31 Yokohama 27 Kashiwa 20 Sapporo 20 Sendai 18
Narrow the registerReset
Recruitment status
Phase
Site location
Nagoya31 Yokohama27 Kashiwa20 Sapporo20 Sendai18
All 142 locations
Target enrolment
to

Trials with a site in Kashiwa

20 of 2493 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Japan
Start
Recruiting
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
NCT07227298Advanced/Metastatic Non-Small Cell Lung Cancer, Carcinoma, Non-Small Cell Lung, Non-Small Cell Lung Cancer
Pfizer
Phase 1/2
162
Kashiwa, Sendai, Hirakata, Nagaizumi-cho, Bunkyo-ku
2026-01-30
Recruiting
Pfizer
Phase 3
800
Nagoya, Chiba, Kashiwa, Yokohama, Hidaka, Kitaadachi-gun, Nagaizumi-cho, Koto-ku
2025-12-11
Recruiting
Pfizer
Phase 1/2
138
Nagoya, Kashiwa, Sakai, Chuo-ku, Fukuoka
2025-12-01
Recruiting
Pfizer
Phase 2/3
982
Nagoya, Chiba, Kashiwa, Kita-gun, Kawasaki, Yokohama, Suita, Nagaizumi-cho
2025-10-03
Recruiting
Pfizer
Phase 3
900
Chiba, Kashiwa, Matsuyama, Sapporo, Kobe, Kanazawa, Yokohama, Yokosuka
2024-10-22
Active, closed
Pfizer
Phase 3
600
Chiba, Kashiwa, Matsuyama, Sapporo, Kobe, Kanazawa, Yokohama, Yokosuka
2024-10-21
Active, closed
Pfizer
Phase 1/2
71
Kashiwa, Yokohama, Chuo-ku, Tokyo
2024-02-19
Active, closed
Pfizer
Phase 3
59
Nagoya, Kashiwa, Chuo-ku
2023-08-09
Active, closed
Pfizer
Phase 3
624
Nagoya, Chiba, Kashiwa, Sapporo, Yokohama, Suita, Ina-machi, Bunkyo-ku
2023-03-03
Recruiting
Pfizer
Phase 2
36
Kashiwa, Nagareyama-shi, Maebashi, Nishinomiya, Ikoma, Saitama-shi, Shimotsuke, Bunkyo-ku
2022-12-16
Active, closed
Pfizer
Phase 1
148
Kashiwa, Hirakata
2022-11-30
Active, closed
Pfizer
Phase 1
6
Nagoya, Kashiwa, Chuo-ku
2022-08-16
Active, closed
Pfizer
Phase 3
599
Nagoya, Hirosaki, Chiba, Kashiwa, Matsuyama, Fukuoka, Kure, Sapporo
2021-05-12
Active, closed
Pfizer
Phase 3
841
Chiba, Kashiwa, Sapporo, Kanazawa, Kawasaki, Yokohama, Nagoya, Osaka
2020-12-21
Recruiting
Study of PF-07248144 in Advanced or Metastatic Solid Tumors
NCT04606446Locally Advanced or Metastatic ER+ HER2- Breast Cancer, Locally Advanced or Metastatic Castration-resistant Prostate Cancer, Locally Advanced or Metastatic Non-small Cell Lung Cancer
Pfizer
Phase 2
320
Nagoya, Kashiwa, Yokohama, Chuo-ku
2020-11-16
Recruiting
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
NCT04557449Liposarcoma, Prostate Cancer, Advanced Breast Cancer, NSCLC (Non-small Cell Lung Cancer)
Pfizer
Phase 1/2
430
Kashiwa
2020-09-23
Recruiting
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
NCT03460977Metastatic Castration Resistant Prostate Cancer (mCRPC), Small Cell Lung Cancer (SCLC), Follicular Lymphoma (FL)
Pfizer
Phase 1
453
Kashiwa
2018-04-17
Active, closed
Pfizer
Phase 3
1,054
Nagoya, Hirosaki, Kashiwa, Matsuyama, Kure, Sapporo, Kanazawa, Yokohama
2017-12-18
Rows per page Showing 1–20 of 20
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Japanese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 22 October 2026. https://priyalifescience.com/clinical-trials-japan/city/kashiwa

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Japan and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,493 studies in total at the last sync on 22 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 20 of those studies with a site in Kashiwa that also match the filters currently applied.

How many clinical trials are recruiting in Kashiwa?

10 of the 20 studies on this page are recruiting new participants as of the 22 Oct 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 10 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Kashiwa), 20 studies
PhaseStudiesRecruitingShare
Phase 39345%
Phase 1/24320%
Phase 13115%
Phase 23215%
Phase 2/3115%

Most active sponsors

Lead sponsors with the most studies (Kashiwa)
Lead sponsorStudiesRecruiting
Pfizer2010
→

Other trial registries in Japan

This register lists Japan studies from ClinicalTrials.gov. Many studies in Japan are registered only in a national registry. We do not copy those records; search them directly:

  • jRCT (Japan Registry of Clinical Trials) — run by the Ministry of Health, Labour and Welfare; trials under Japan's Clinical Trials Act and other clinical research
  • UMIN-CTR — run by the University of Tokyo Hospital's UMIN Center; many academic and investigator-led studies
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.